Stocks moving the most at midday: Nike, Rent-A-Center, Carnival Cruise

People walk near the entrance to the Nike store on May 25, 2022 in Moscow, Russia.

Konstantin Zavrazhin | Getty Images News | Getty Images

Find out which companies are making headlines in the midday business.

Nike – Shares of Nike fell 12% after the sneaker giant said Thursday its inventory was overstocked, up 44% in its most recent quarter. As a result, it will offer more discounts to eliminate excess goods. Other retailers were also dragged lower, with Lululemon Athletica and Under Armor losing nearly 6% and nearly 5% respectively.

Rent-A-Center – Shares of Rent-A-Center fell 20% after the company cut its profit forecast for the current quarter, saying economic conditions weighed on consumer traffic and habits of payment.

Carnival Cruise – Carnival Cruise shares fell nearly 20% after the company forecast a fourth-quarter loss, saying high fuel prices and inflation would delay its return to profitability. Royal Caribbean and Norwegian Cruise Lines also fell, dropping 11% and 14% respectively.

Micron – Shares of Micron rose 1.5% after the company reported quarterly results that beat Wall Street expectations, even as sales fell. The chipmaker also gave a weaker-than-expected revenue outlook, saying sales are hurt by slowing consumer demand.

Charles River Laboratories – Shares of Charles River rose 6% after Jefferies upgraded the stock to buy on hold, citing the company’s potential in animal studies.

Twitter – Twitter’s shares rose 1.5% after texts between its founder, Jack Dorsey, and Elon Musk were published in court filings. The Tesla CEO is embroiled in a legal battle over his bid to buy the social media company.

Nucor – Shares of steel company Nucor jumped 2.7% after it announced plans to spend $425 million to expand a galvanized steel line at its South Carolina plant.

Amylyx Pharmaceuticals – Shares of the pharmaceutical company fell 6.3% despite the shares rallying after hours on Thursday after the Food and Drug Administration announced approval of its controversial Lou’s disease drug Gehrig.

Generac – Shares of Generac gained 4.5% after Cowen initiated coverage of the company with a buy rating. The generator company is a clear winner in the industry and has value in its solar offering.

– CNBC’s Alex Harring and Michelle Fox contributed reporting.

cnbc Business

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.
Back to top button